by Jordana Choucair | Nov 9, 2021 | Life Sciences
Pfizer is expected to seek FDA authorization as soon as this week for a booster shot for people 18 and older. According to three officials, the agency is likely to clear the shots. The move could increase booster rates at a time when COVID-19 cases and deaths appear...
by Jordana Choucair | Nov 9, 2021 | Life Sciences
Merck & Co. announced that the federal government will buy another $1 billion worth its COVID-19 pill called molnupiravir. The government spent $1.2 billion on 1.7 million courses of the drug in June and is now exercising its option to buy 1.4 million more. In...
by Jordana Choucair | Nov 9, 2021 | D.C. News
The Biden administration defended its COVID-19 vaccination mandate for large employers in a court filing, arguing that the requirement is necessary to prevent hospitalizations and deaths and that it falls within the Department of Labor’s authority. The court...
by Jordana Choucair | Nov 8, 2021 | D.C. News
A federal appeals court on Saturday temporarily blocked the Biden administration’s vaccine mandate for private businesses with 100 or more employees, health care workers, and federal contractors. The court gave the federal government until 5:00pm today to respond....
by Jordana Choucair | Nov 8, 2021 | D.C. News
The House late Friday cleared a Senate-passed bipartisan infrastructure bill by a vote of 228-206. All but six Democrats voting for the measure, along with 13 Republicans. The bipartisan bill would reauthorize surface transportation and water programs for five years,...
by Jordana Choucair | Nov 8, 2021 | Public Health/Prevention
After 20 months, federal restrictions lifted today for vaccinated international travelers. Travelers from many countries – including Mexico, Canada, and most of Europe – will still be required to show a negative COVID-19 test to enter the United States. Industry...
Recent Comments